Gilead Sciences: Disappointing Fundamentals And Sentiment, But Still Bullish (NASDAQ:GILD)

Date:


Impf- oder Arzneimittelkonzeptbild mit Coronavirus Covid-19

ffikretow/iStock via Getty Images

My last article about Gilead Sciences, Inc. (NASDAQ:GILD) was published in August 2023 and once again the stock declined while the overall market outperformed. Back then, the stock was trading for $77, and Gilead Sciences declined 12% while the



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Supreme Court Upholds Law Disarming Domestic Abusers

The Supreme Court ruled on Friday that the...

Is Israel’s Smotrich fulfilling his dream of annexing the West Bank? | Israel-Palestine conflict News

About a month ago, a quiet transfer happened. The...

Amazon’s new AI-powered Alexa might cost up to $10 per month

Last year, David Limp, Amazon’s former senior vice...